5-HT2A receptor polymorphism may modulate antipsychotic treatment response in Alzheimer's disease

被引:3
作者
Engelborghs, S
Holmes, C
McCulley, M
De Deyn, PP
机构
[1] Univ Antwerp, Lab Neurochem & Behav, Born Bunge Fdn, B-2610 Antwerp, Belgium
[2] Univ Southampton, Sch Med, Southampton, Hants, England
[3] Univ Southampton, Neurochem Lab, Southampton SO9 5NH, Hants, England
关键词
D O I
10.1002/gps.1179
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
[No abstract available]
引用
收藏
页码:1108 / 1109
页数:2
相关论文
共 5 条
[1]   Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response [J].
Arranz, MJ ;
Munro, J ;
Sham, P ;
Kirov, G ;
Murray, RM ;
Collier, DA ;
Kerwin, RS .
SCHIZOPHRENIA RESEARCH, 1998, 32 (02) :93-99
[2]   A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia [J].
De Deyn, PP ;
Rabheru, K ;
Rasmussen, A ;
Bocksberger, JP ;
Dautzenberg, PLJ ;
Eriksson, S ;
Lawlor, BA .
NEUROLOGY, 1999, 53 (05) :946-955
[3]   5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer's disease [J].
Holmes, C ;
Arranz, MJ ;
Powell, JF ;
Collier, DA ;
Lovestone, S .
HUMAN MOLECULAR GENETICS, 1998, 7 (09) :1507-1509
[4]  
LEYSEN JE, 1985, HDB NEUROCHEMISTRY
[5]   STIMULATION OF SERUM CORTISOL AND PROLACTIN SECRETION IN HUMANS BY MK-212, A CENTRALLY ACTIVE SEROTONIN AGONIST [J].
LOWY, MT ;
MELTZER, HY .
BIOLOGICAL PSYCHIATRY, 1988, 23 (08) :818-828